Sinovac, Pfizer-BioNtech COVID-19 vaccines prove highly effective in Uruguay — government | Inquirer News

Sinovac, Pfizer-BioNtech COVID-19 vaccines prove highly effective in Uruguay — government

/ 07:05 AM June 09, 2021

Non-medical essential workers receive China's SINOVAC vaccine

FILE PHOTO: A healthcare worker stands during the first stage of COVID-19 vaccination plan, which aims to inoculate teachers, military personnel, firefighters and police officers, among other non medical essential workers, at a vaccination center in Antel Arena, Montevideo, Uruguay March 1, 2021. REUTERS/Mariana Greif

ASUNCION — Uruguay on Tuesday released real-world data on the impact of Sinovac Biotech’s COVID-19 vaccine among its population that showed it was over 90% effective in preventing intensive care admissions and deaths.

The shot reduced deaths by 95% and intensive care admissions by 92%, and also showed 61% efficacy in cutting coronavirus infections, the government said.

ADVERTISEMENT

A total of 795,684 people – health workers and members of the general population between the ages of 18 and 69 – at least 14 days after receiving their second dose of Sinovac’s CoronaVac were compared to unvaccinated people to determine the real-world vaccine effectiveness, the government said in a report.

FEATURED STORIES

The government also studied the effectiveness of the Pfizer/BioNTech vaccine among 162,047 health workers and people over 80 years old. The shot was 94% effective at preventing intensive care unit admissions and deaths, and reduced infections by 78%, the report said.

Overall, intensive care hospitalizations and deaths from COVID-19 dropped by more than 90% among Uruguayans who were fully-inoculated, the data showed.

The tiny Latin nation with a population of 3.5 million managed to largely hold COVID-19 at bay with a strict lockdown last year. This year, it has seen a spike in cases that in recent weeks propelled it to the ranks of countries with the highest COVID-19 death rates per million, according to Our World in Data figures.

So far, it has vaccinated almost 52% of its population with at least one dose of COVID-19 vaccine from Sinovac, Pfizer/BioNTech or AstraZeneca, received through the COVAX vaccine alliance, while 29% had been fully vaccinated, between the end of February and June 1, according to Ministry of Health data.

Uruguay has registered 318,783 cases of COVID-19 since March 2020 and 4,692 associated deaths.

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

TAGS: Sinovac, Uruguay

© Copyright 1997-2024 INQUIRER.net | All Rights Reserved

We use cookies to ensure you get the best experience on our website. By continuing, you are agreeing to our use of cookies. To find out more, please click this link.